My Member Center

Pharmaceutical Access

image alt text
Photo: Justin Veneman, St. Jude Children’s Research Hospital; Memphis, Tenn.

Understanding Pharmaceuticals

Latest Update

  • Congress is currently reviewing competing drug packages: H.R. 3, the Lower Drug Costs Now Act of 2019 and S. 2543, the Prescription Drug Pricing Reduction Act.

  • The Centers for Medicare & Medicaid Services announced a plan to collect 340B drug acquisition costs from hospitals. 

COVID-19 Update: our resource hub for children’s hospitals tracks policy-related resources helpful to your work during the COVID-19 crisis.

 

Featured Resource

Resource Image
Fact Sheet
The Effects of Drug Shortages on Children's Hospitals and Their Patients September 24, 2020

How children's hospitals are facing drug shortages.

Resources

Narrow By:

Toolkit
COVID-19: Policy Resources for Children's Hospitals
April 9, 2021

This resource hub is designed to help you track policy-related resources helpful to your work during the COVID-19 crisis.

Analysis or Summary
Congressional Relief Legislation and Children's Hospitals Requests in Response to COVID-19
April 1, 2021

Multiple packages for COVID-19 relief have passed to date. Read more about them here.

Analysis or Summary
CHA summary of final surprise billing legislation – the "No Surprises Act"
December 29, 2020

President Trump signed the "No Surprises Act" to address surprise billing.

Press Release
Hospitals and Pharmacists File Lawsuit Over Drug Companies' Refusals of 340B Discounts
December 11, 2020

CHA and other hospital organizations filed a federal lawsuit today against HHS over the department's failure to enforce 340 Drug Discount Program requirements and halt drug company actions that undermine the program.

Analysis or Summary
CY 2021 Medicare OPPS Final Rule Summary
December 8, 2020

CMS released the CY 2021 Medicare OPPS final rule.

Letter or Testimony
Republican lawmakers request 340B stakeholder feedback
October 23, 2020

Republican lawmakers called on stakeholders to submit improvement ideas for the 340B program.

Analysis or Summary
Implications for Children of ACA Constitutionality Case
October 22, 2020

The Fifth Circuit Court of Appeals ruled that the ACA's individual mandate and the entire law is unconstitutional.

Fact Sheet
The Effects of Drug Shortages on Children's Hospitals and Their Patients
September 24, 2020

How children's hospitals are facing drug shortages.

Analysis or Summary
FY 2021 Medicare IPPS Final Rule Summary
September 17, 2020

CMS' released the FY 2021 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule.

Analysis or Summary
Section 1557 Final Rule Summary Highlights Roll Back of Nondiscrimination Protections; Impact of Recent Court Actions
August 28, 2020

HHS released a final rule to roll back key aspects of a former rule that implemented the ACA's non-discrimination provisions, known as Section 1557.

Article
Research Confirms Drug Shortages Disproportionately Affect Children’s Hospitals
May 4, 2020

A project conducted by Vizient and CHA informs strategies to limit shortages of essential drugs in children’s hospitals.

Letter or Testimony
Allied 340B Groups Urge Senate Finance Leaders to Protect 340B
April 14, 2020

The 340B Coalition sent a letter to Senate Finance leadership asking them to prevent any changes to the 340B Drug Discount Program.

Letter or Testimony
CHA Submits Comments to OMB on Proposed 340B Hospital Survey
March 11, 2020

We submitted a comment letter on CMS' proposed hospital survey on 340B drug acquisition costs.

Analysis or Summary
Summary of Recent 340B Regulatory Developments
February 13, 2020

CHA developed a summary of federal regulatory activities related to the 340B program.

Analysis or Summary
MedPAC Examines 340B Drug Discount Program
January 23, 2020

On Jan. 17, 2020, MedPAC discussed whether the 340B program creates incentives for participating hospitals to use more expensive drugs.

Analysis or Summary
2019 State Child Health Policy Trends
January 10, 2020

This CHA report provides an analysis of state child health policy trends identified through calls with GRs and state children's hospital associations.

Analysis or Summary
CY 2020 Medicare OPPS Final Rule
December 31, 2019

CMS released the CY 2020 Medicare Hospital Outpatient Prospective Payment System final rule.

Analysis or Summary
Cures 2.0: CHA Letter Responding to RFI
December 18, 2019

CHA submitted comments to the request for information on a Cures 2.0 package.

Analysis or Summary
CMS announces plan to collect 340B drug acquisition price information
December 2, 2019

CMS announced a proposed hospital survey for specified covered outpatient drugs.

Letter or Testimony
CHA endorses MEDS Act
November 6, 2019

CHA joined over 50 allied health partners in supporting S. 2723, the MEDS Act.

Letter or Testimony
CHA Endorses House Bill to Boost Support for Pediatric Researchers
October 24, 2019

CHA endorses bill to increase support for pediatric researchers.

Letter or Testimony
CHA Supports VACCINES Act of 2019
June 13, 2019

Analysis or Summary
Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Proposed Rule
May 23, 2019

On May 23, CMS published a final rule in the Federal Register to modernize Part D and Medicare Advantage.

Article
Minimizing Opioid Misuse in Adults and Treating Pain in Children
April 26, 2019

This pain management advocate shares his thoughts on opioids and pediatric patients.

Analysis or Summary
Summary of Final Annual Guidance for Private Insurance Plans
April 25, 2019

This CHA summary of the 2020 Final Notice of Benefits and Payment Parameters highlights several policies that could impact children’s commercial health coverage.

Load More Results

Contacts

Newsletters

Policy Update Calls

Members receive the latest updates and suggest ways to best influence policy issues that impact children's health and children's hospitals in a weekly conference call.

Champions for Children's Health

©Children's Hospital Association